Cytogen, Inc. Stock

A217330

KR7217330000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-08-07			5-day change	1st Jan Change
3,430.00 ^KRW	0.00%		+11.91%	-61.85%

05-17	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE

Cytogen Inc is a Korea-based company mainly engaged in the provision of liquid biopsy application services. The liquid biopsy application services include biomarker discovery and verification services, as well as liquid biopsy-based precision medical services which is the commercialization of companion diagnostics (CDx) development, among others. The biomarker discovery and verification services include circulating tumor cell (CTC)-based biomarker discovery and validation, gene mutation and transcript expression analysis, and drug testing and analysis services, among others. The liquid biopsy-based precision healthcare services include companion diagnosis, re-selection of therapeutic drugs, examination and treatment effectiveness monitoring, and recurrence prediction services, among others. In addition, the Company develops and sells platforms and kits for liquid biopsy. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-08-07	₩3,430.00	0.00%	46,235
26-08-06	₩3,430.00	+0.29%	71,611
26-08-05	₩3,420.00	+3.17%	59,422
26-08-04	₩3,315.00	+6.25%	105,021
26-08-03	₩3,120.00	+1.79%	63,725

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
A217330 Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	79.13B 56.14M 48.56M 45.35M 41.6M 78.25M 5.34B 79.49M 532M 209M 2.68B 211M 206M 8.85B	P/E 2024	-5.98x	P/E 2025	-16.8x
Enterprise Value	63.9B 45.33M 39.21M 36.62M 33.59M 63.18M 4.31B 64.19M 430M 169M 2.16B 170M 167M 7.15B	EV / Sales 2024	7.17x	EV / Sales 2025	7.38x
Free-Float	54.99%	Yield 2024 *	-	Yield 2025	-

05-17	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE
25-09-10	Cytogen sells 160 million won worth of own shares	RE
25-01-02	Cytogen Moves to Dual CEO Arrangement	MT
24-09-22	Cytogen, Inc.(KOSDAQ:A217330) dropped from S&P Global BMI Index	CI
24-08-21	Cytogen, Inc. announced that it has received KRW 6.500000445 billion in funding from Theragen Etex Co.,Ltd.	CI
24-07-30	Cytogen, Inc. agreed to acquire 98.95% stake in Theragen Genomecare Co. Ltd from Theragen Etex Co.,Ltd. and Daeilgen Bio for KRW 13.2 billion.	CI
24-03-19	Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
24-03-17	Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
23-12-27	Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited	CI
23-12-27	Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited	CI
23-12-18	Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion	CI
23-10-26	Cytogen, Inc. announces tranche update	CI

1 week	+11.91%
Current month	+11.91%
1 month	+15.68%
3 months	-42.64%
6 months	-49.56%
Current year	-61.85%

1 week	2,940	3,500
1 month	2,760	3,500
Current year	2,760	11,200
1 year	2,260	11,200
3 years	2,260	19,330
5 years	2,260	24,166.67
10 years	2,260	24,166.67

Manager	Title	Age	Since
Ji-Hun Ahn CEO	Chief Executive Officer	45	2025-01-01
Byeong-Hui Jeon CEO	Chief Executive Officer	67	2025-01-01
Young-Woong Son PRN	Corporate Officer/Principal	52	2025-03-30

Cytogen, Inc. Stock

Stocks

A217330

KR7217330000

Biotechnology & Medical Research

Valuation: Cytogen, Inc.

Chart: Cytogen, Inc.

Latest news : Cytogen, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Cytogen, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Director	Title	Age	Since
Byeong-Hui Jeon BRD	Director/Board Member	67	2025-01-01
Ji-Hun Ahn BRD	Director/Board Member	45	2025-01-01
Seung-Gi Min BRD	Director/Board Member	64	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYTOGEN, INC.	0.00%	+11.91%	+24.73%	-79.88%	56.14M
LONZA GROUP AG	+0.99%	+1.78%	+5.07%	+16.49%	49.47B
REVOLUTION MEDICINES, INC.	+3.71%	+9.40%	+486.14%	+579.98%	43.61B
BEONE MEDICINES AG	+5.60%	+10.21%	+20.85%	+81.78%	39.6B
IQVIA HOLDINGS INC.	+2.70%	+1.57%	+32.71%	+9.07%	39.29B
CELLTRION, INC.	+2.21%	+6.75%	+20.20%	+54.40%	32.43B
ASCENDIS PHARMA A/S	+2.23%	+4.71%	-	-	16.84B
MEDPACE HOLDINGS, INC.	+0.97%	+2.35%	+35.99%	+124.45%	16.49B
EUROFINS SCIENTIFIC SE	-0.11%	+2.41%	+5.03%	+20.47%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.75%	+15.04%	+79.84%	+29.70%	12.77B
Average	+1.90%	+6.68%	+78.95%	+92.94%	26.46B
Weighted average by Cap.	+2.54%	+6.10%	+104.57%	+137.99%

	2024	2025
Net sales	10.91B 7.74M 6.7M 6.25M 5.74M 10.79M 737M 10.96M 73.36M 28.8M 369M 29.07M 28.43M 1.22B	26.05B 18.49M 15.99M 14.93M 13.7M 25.76M 1.76B 26.17M 175M 68.76M 882M 69.42M 67.9M 2.92B
Net income	-17.12B -12.14M -10.5M -9.81M -9M -16.93M -1.16B -17.2M -115M -45.17M -579M -45.6M -44.61M -1.92B	-12.34B -8.76M -7.58M -7.07M -6.49M -12.21M -833M -12.4M -82.99M -32.58M -418M -32.89M -32.17M -1.38B
Net Debt	-26.39B -18.73M -16.2M -15.13M -13.88M -26.1M -1.78B -26.52M -177M -69.66M -893M -70.32M -68.78M -2.95B	-15.23B -10.81M -9.35M -8.73M -8.01M -15.06M -1.03B -15.3M -102M -40.2M -516M -40.59M -39.7M -1.7B